The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis

<table>Meta-analysis of the three case-control studies of MS and the PAI-1 4G/5G and TPA I/D polymorphisms. Comparisons were made between the PAI-1 5G5G/TPA I carriers and other genotype/carrier combinations. Summary ORs and respective 95% CIs were calculated using the fixed-effect model.</table>

Disease Markers

fig3

Figure 3

Figure 3: The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis 